Qualigen Therapeutics, Inc.·4

Apr 19, 6:15 AM ET

Lotz Christopher L. 4

4 · Qualigen Therapeutics, Inc. · Filed Apr 19, 2021

Insider Transaction Report

Form 4
Period: 2021-04-16
Lotz Christopher L.
VP of Finance, CFO.
Transactions
  • Purchase

    Common Stock

    2021-04-16$1.86/sh+2,700$5,02212,541 total

Documents

1 file
  • 4
    ownership.xmlPrimary